Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Have The Biotech Stocks Topped Out?

Published 04/09/2013, 12:14 AM
Updated 07/09/2023, 06:31 AM
NDX
-
IBB
-
COST
-
AMGN
-
BIIB
-
CELG
-
NBI
-
ABE
-

The biotech stocks have the been one of the leading stocks sectors throughout 2012 and 2013. The Market Vectors Biotech ETF (BBH) has rallied higher by more than $36.00 since August 10, 2011. Today, the BBH is trading lower by 0.41 cents to $64.32 a share. The BBH looks very overbought and extended on the daily and weekly charts. This tells us that a pullback should be expected as it is very overdue. Short term traders should watch for intra-day support on the BBH around the $63.70, and $62.30 levels. The daily chart will likely have support around the $60.00 area.

Some other biotech ETF's that traders can follow include the SPDR S&P Biotech (ETF) (XBI), and the iShares NASDAQ Biotechnology Index (ETF) (IBB). Some of the leading biotech stocks that make up a large part of these ETF's include Amgen Inc (AMGN), Celgene Corporation (CELG), and Biogen Idec Inc (BIIB). All of these stocks have traded very similar chart patterns to the biotech ETF's so they are very susceptible to pullbacks at this time.
BBH

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.